메뉴 건너뛰기




Volumn 54, Issue 8, 2010, Pages 3149-3154

Risk factors for fluconazole-resistant candidemia

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CORTICOSTEROID; FLUCONAZOLE;

EID: 77955395004     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00479-10     Document Type: Article
Times cited : (98)

References (31)
  • 4
    • 0037096886 scopus 로고    scopus 로고
    • Antifungal prophylaxis for severely neutropenic chemotherapy recipients: A meta analysis of randomized-controlled clinical trials
    • Bow, E. J., M. Laverdiere, N. Lussier, C. Rotstein, M. S. Cheang, and S. Ioannou. 2002. Antifungal prophylaxis for severely neutropenic chemotherapy recipients: a meta analysis of randomized-controlled clinical trials. Cancer 94:3230-3246.
    • (2002) Cancer , vol.94 , pp. 3230-3246
    • Bow, E.J.1    Laverdiere, M.2    Lussier, N.3    Rotstein, C.4    Cheang, M.S.5    Ioannou, S.6
  • 6
    • 23044487160 scopus 로고    scopus 로고
    • Fluconazole MIC and the fluconazole dose/MIC ratio correlate with therapeutic response among patients with candidemia
    • Clancy, C. J., V. L. Yu, A. J. Morris, D. R. Snydman, and M. H. Nguyen. 2005. Fluconazole MIC and the fluconazole dose/MIC ratio correlate with therapeutic response among patients with candidemia. Antimicrob. Agents Chemother. 49:3171-3177.
    • (2005) Antimicrob. Agents Chemother. , vol.49 , pp. 3171-3177
    • Clancy, C.J.1    Yu, V.L.2    Morris, A.J.3    Snydman, D.R.4    Nguyen, M.H.5
  • 7
    • 33646455889 scopus 로고    scopus 로고
    • Antifungal prophylaxis in liver transplant patients: A systematic review and meta-analysis
    • Cruciani, M., C. Mengoli, M. Malena, O. Bosco, G. Serpelloni, and P. Grossi. 2006. Antifungal prophylaxis in liver transplant patients: a systematic review and meta-analysis. Liver Transpl. 12:850-858.
    • (2006) Liver Transpl. , vol.12 , pp. 850-858
    • Cruciani, M.1    Mengoli, C.2    Malena, M.3    Bosco, O.4    Serpelloni, G.5    Grossi, P.6
  • 9
    • 34247181114 scopus 로고    scopus 로고
    • Epidemiology, risk factors, and outcomes of Candida albicans versus non-albicans candidemia in nonneutropenic patients
    • Davis, S. L., J. A. Vazquez, and P. S. McKinnon. 2007. Epidemiology, risk factors, and outcomes of Candida albicans versus non-albicans candidemia in nonneutropenic patients. Ann. Pharmacother. 41:568-573.
    • (2007) Ann. Pharmacother. , vol.41 , pp. 568-573
    • Davis, S.L.1    Vazquez, J.A.2    McKinnon, P.S.3
  • 10
    • 38549163599 scopus 로고    scopus 로고
    • Candida albicans versus non-albicans intensive care unit-acquired bloodstream infections: Differences in risk factors and outcome
    • Dimopoulos, G., F. Ntziora, G. Rachiotis, A. Armaganidis, and M. E. Falagas. 2008. Candida albicans versus non-albicans intensive care unit-acquired bloodstream infections: differences in risk factors and outcome. Anesth. Analg. 106:523-529.
    • (2008) Anesth. Analg. , vol.106 , pp. 523-529
    • Dimopoulos, G.1    Ntziora, F.2    Rachiotis, G.3    Armaganidis, A.4    Falagas, M.E.5
  • 11
    • 33746070016 scopus 로고    scopus 로고
    • Attributable mortality of candidemia: A systematic review of matched cohort and casecontrol studies
    • Falagas, M. E., K. E. Apostolou, and V. D. Pappas. 2006. Attributable mortality of candidemia: a systematic review of matched cohort and casecontrol studies. Eur. J. Clin. Microbiol. Infect. Dis. 25:419-425.
    • (2006) Eur. J. Clin. Microbiol. Infect. Dis. , vol.25 , pp. 419-425
    • Falagas, M.E.1    Apostolou, K.E.2    Pappas, V.D.3
  • 12
    • 53649097545 scopus 로고    scopus 로고
    • Trends in species distribution and susceptibility of bloodstream isolates of Candida collected in Monterrey, Mexico, to seven antifungal agents: Results of a 3-year (2004 to 2007) surveillance study
    • Gonzalez, G. M., M. Elizondo, and J. Ayala. 2008. Trends in species distribution and susceptibility of bloodstream isolates of Candida collected in Monterrey, Mexico, to seven antifungal agents: results of a 3-year (2004 to 2007) surveillance study. J. Clin. Microbiol. 46:2902-2905.
    • (2008) J. Clin. Microbiol. , vol.46 , pp. 2902-2905
    • Gonzalez, G.M.1    Elizondo, M.2    Ayala, J.3
  • 14
    • 56049120807 scopus 로고    scopus 로고
    • Treatment-related risk factors for hospital mortality in Candida bloodstream infections
    • Labelle, A. J., S. T. Micek, N. Roubinian, and M. H. Kollef. 2008. Treatment-related risk factors for hospital mortality in Candida bloodstream infections. Crit. Care Med. 36:2967-2972.
    • (2008) Crit. Care Med. , vol.36 , pp. 2967-2972
    • Labelle, A.J.1    Micek, S.T.2    Roubinian, N.3    Kollef, M.H.4
  • 16
    • 27644585171 scopus 로고    scopus 로고
    • Prior antimicrobial therapy and risk for hospitalacquired Candida glabrata and Candida krusei fungemia: A case-case-control study
    • Lin, M. Y., Y. Carmeli, J. Zumsteg, E. L. Flores, J. Tolentino, P. Sreeramoju, and S. G. Weber. 2005. Prior antimicrobial therapy and risk for hospitalacquired Candida glabrata and Candida krusei fungemia: a case-case-control study. Antimicrob. Agents Chemother. 49:4555-4560.
    • (2005) Antimicrob. Agents Chemother. , vol.49 , pp. 4555-4560
    • Lin, M.Y.1    Carmeli, Y.2    Zumsteg, J.3    Flores, E.L.4    Tolentino, J.5    Sreeramoju, P.6    Weber, S.G.7
  • 17
    • 14744289081 scopus 로고    scopus 로고
    • Candida krusei fungaemia: Antifungal susceptibility and clinical presentation of an uncommon entity during 15 years in a single general hospital
    • Muñoz, P., M. Sanchez-Somolinos, L. Alcala, M. Rodriguez-Creixems, T. Pelaez, and E. Bouza. 2005. Candida krusei fungaemia: antifungal susceptibility and clinical presentation of an uncommon entity during 15 years in a single general hospital. J. Antimicrob. Chemother. 55:188-193.
    • (2005) J. Antimicrob. Chemother. , vol.55 , pp. 188-193
    • Muñoz, P.1    Sanchez-Somolinos, M.2    Alcala, L.3    Rodriguez-Creixems, M.4    Pelaez, T.5    Bouza, E.6
  • 19
    • 33644596969 scopus 로고    scopus 로고
    • Invasive candidiasis in the intensive care unit
    • Ostrosky-Zeichner, L., and P. G. Pappas. 2006. Invasive candidiasis in the intensive care unit. Crit. Care Med. 34:857-863.
    • (2006) Crit. Care Med. , vol.34 , pp. 857-863
    • Ostrosky-Zeichner, L.1    Pappas, P.G.2
  • 21
    • 34548138992 scopus 로고    scopus 로고
    • Adequacy of empirical antifungal therapy and effect on outcome among patients with invasive Candida species infections
    • Parkins, M. D., D. M. Sabuda, S. Elsayed, and K. B. Laupland. 2007. Adequacy of empirical antifungal therapy and effect on outcome among patients with invasive Candida species infections. J. Antimicrob. Chemother. 60:613-618.
    • (2007) J. Antimicrob. Chemother. , vol.60 , pp. 613-618
    • Parkins, M.D.1    Sabuda, D.M.2    Elsayed, S.3    Laupland, K.B.4
  • 22
    • 0038627919 scopus 로고    scopus 로고
    • Variation in susceptibility of bloodstream isolates of Candida glabrata to fluconazole according to patient age and geographic location
    • Pfaller, M. A., S. A. Messer, L. Boyken, S. Tendolkar, R. J. Hollis, and D. J. Diekema. 2003. Variation in susceptibility of bloodstream isolates of Candida glabrata to fluconazole according to patient age and geographic location. J. Clin. Microbiol. 41:2176-2179.
    • (2003) J. Clin. Microbiol. , vol.41 , pp. 2176-2179
    • Pfaller, M.A.1    Messer, S.A.2    Boyken, L.3    Tendolkar, S.4    Hollis, R.J.5    Diekema, D.J.6
  • 23
    • 47249139580 scopus 로고    scopus 로고
    • Candidemia in nonneutropenic critically ill patients: Risk factors for non-albicans Candida spp
    • Playford, E. G., D. Marriott, Q. Nguyen, S. Chen, D. Ellis, M. Slavin, and T. C. Sorrell. 2008. Candidemia in nonneutropenic critically ill patients: risk factors for non-albicans Candida spp. Crit. Care Med. 36:2034-2039.
    • (2008) Crit. Care Med. , vol.36 , pp. 2034-2039
    • Playford, E.G.1    Marriott, D.2    Nguyen, Q.3    Chen, S.4    Ellis, D.5    Slavin, M.6    Sorrell, T.C.7
  • 27
    • 24944510786 scopus 로고    scopus 로고
    • Fluconazole prophylaxis in critically ill surgical patients: A meta-analysis
    • Shorr, A. F., K. Chung, W. L. Jackson, P. E. Waterman, and M. H. Kollef. 2005. Fluconazole prophylaxis in critically ill surgical patients: a meta-analysis. Crit. Care Med. 33:1928-1935.
    • (2005) Crit. Care Med. , vol.33 , pp. 1928-1935
    • Shorr, A.F.1    Chung, K.2    Jackson, W.L.3    Waterman, P.E.4    Kollef, M.H.5
  • 28
    • 34247099393 scopus 로고    scopus 로고
    • Do clinical features allow for accurate prediction of fungal pathogenesis in bloodstream infections? Potential implications of the increasing prevalence of non-albicans candidemia
    • Shorr, A. F., D. R. Lazarus, J. H. Sherner, W. L. Jackson, M. Morrel, V. J. Fraser, and M. H. Kollef. 2007. Do clinical features allow for accurate prediction of fungal pathogenesis in bloodstream infections? Potential implications of the increasing prevalence of non-albicans candidemia. Crit. Care Med. 35:1077-1083.
    • (2007) Crit. Care Med. , vol.35 , pp. 1077-1083
    • Shorr, A.F.1    Lazarus, D.R.2    Sherner, J.H.3    Jackson, W.L.4    Morrel, M.5    Fraser, V.J.6    Kollef, M.H.7
  • 30
    • 2942741307 scopus 로고    scopus 로고
    • Clinical factors associated with fluconazole resistance and short-term survival in patients with Candida bloodstream infection
    • Takakura, S., N. Fujihara, T. Saito, T. Kudo, Y. Iinuma, and S. Ichiyama. 2004. Clinical factors associated with fluconazole resistance and short-term survival in patients with Candida bloodstream infection. Eur. J. Clin. Microbiol. Infect. Dis. 23:380-388.
    • (2004) Eur. J. Clin. Microbiol. Infect. Dis. , vol.23 , pp. 380-388
    • Takakura, S.1    Fujihara, N.2    Saito, T.3    Kudo, T.4    Iinuma, Y.5    Ichiyama, S.6
  • 31
    • 33645833237 scopus 로고    scopus 로고
    • Antifungal prophylaxis with azoles in high-risk, surgical intensive care unit patients: A meta-analysis of randomized, placebo-controlled trials
    • Vardakas, K. Z., G. Samonis, A. Michalopoulos, E. S. Soteriades, and M. E. Falagas. 2006. Antifungal prophylaxis with azoles in high-risk, surgical intensive care unit patients: a meta-analysis of randomized, placebo-controlled trials. Crit. Care Med. 34:1216-1224.
    • (2006) Crit. Care Med. , vol.34 , pp. 1216-1224
    • Vardakas, K.Z.1    Samonis, G.2    Michalopoulos, A.3    Soteriades, E.S.4    Falagas, M.E.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.